Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial (original) (raw)
Fig 3
Longitudinal patterns of taking and timing adherence data of IS-Rifamate using WOT in two participants.
The first participant has highly regular taking and timing adherence, in this case achieved by setting an alarm reminder. The second participant displays variable timing adherence, but taking adherence is maintained with WOT adherence support. INH, isoniazid; IS, ingestion sensor; IS-Rifamate, IS-enabled combination isoniazid 150 mg/rifampin 300 mg; RIF, rifampin; WOT, wirelessly observed therapy.